BUDAPEST, Sept 6 (Reuters) - GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research)(GSK.N: Quote, Profile, Research) will open a 100 million euro ($128.4 million) vaccine manufacturing unit on Friday in the Hungarian town of Godollo, just north of Budapest, a company spokeswoman said.
